Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- 2009
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Aromatase Inhibitors (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Combined Modality Therapy (MeSH)
- Humans (MeSH)
- Selective Estrogen Receptor Modulators (MeSH)
published in
- Cancer Treatment and Research Journal